Medifast Inc
NYSE:MED

Watchlist Manager
Medifast Inc Logo
Medifast Inc
NYSE:MED
Watchlist
Price: 17.91 USD -1.27%
Market Cap: 195.9m USD
Have any thoughts about
Medifast Inc?
Write Note

Medifast Inc
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medifast Inc
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Medifast Inc
NYSE:MED
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Estee Lauder Companies Inc
NYSE:EL
Cash Interest Paid
$364m
CAGR 3-Years
29%
CAGR 5-Years
63%
CAGR 10-Years
19%
Bellring Brands Inc
NYSE:BRBR
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Coty Inc
NYSE:COTY
Cash Interest Paid
$205.7m
CAGR 3-Years
-4%
CAGR 5-Years
-7%
CAGR 10-Years
12%
Inter Parfums Inc
NASDAQ:IPAR
Cash Interest Paid
$7.7m
CAGR 3-Years
59%
CAGR 5-Years
32%
CAGR 10-Years
20%
elf Beauty Inc
NYSE:ELF
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medifast Inc
Glance View

Market Cap
195.9m USD
Industry
Consumer products

Medifast, Inc. engages in the provision of healthy living products and programs. The company is headquartered in Owings Mills, Maryland and currently employs 984 full-time employees. The firm's operations are conducted through its subsidiaries Jason Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Medifast Franchise Systems, Inc., Seven Crondall Associates, LLC, Corporate Events, Inc., OPTAVIA (Hong Kong) Limited, OPTAVIA (Singapore) PTE. LTD and OPTAVIA Health Consultation (Shanghai) Co., Ltd. The firm's product line includes approximately 137 consumable options, including, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company, through Medifast Direct, its direct-to-consumer business unit.

MED Intrinsic Value
20.53 USD
Undervaluation 13%
Intrinsic Value
Price

See Also

Back to Top